STOCK TITAN
  1. Home
  2. Sec-filings
  3. EHC
  4. [Form 4] Encompass Health Corp Insider Trading Activity

Encompass Health (EHC) director Joan Herman granted 1,634 RSUs as annual award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HERMAN JOAN E reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Joan E. Herman received a grant of 1,634 Encompass Health common shares as a compensation award. The shares were granted at no cash cost to Herman as part of an annual restricted stock unit award under the corporation's 2025 Omnibus Performance Incentive Plan. Following this grant, Herman directly holds 49,558 shares of Encompass Health common stock. This is a routine equity compensation grant rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider HERMAN JOAN E
Role null
Type Security Shares Price Value
Grant/Award Encompass Health Common Stock 1,634 $0.00 --
Holdings After Transaction: Encompass Health Common Stock — 49,558 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares granted 1,634 shares Annual restricted stock unit award to director Joan E. Herman
Price per share $0.00 per share Grant price for the 1,634-share award
Holdings after transaction 49,558 shares Total Encompass Health common shares held directly by Herman after grant
Transaction code A Grant, award, or other acquisition of Encompass Health common stock
Transaction date May 7, 2026 Date of restricted stock unit grant
restricted stock units financial
"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Omnibus Performance Incentive Plan financial
"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."
Grant, award, or other acquisition regulatory
"transaction_code_description": "Grant, award, or other acquisition""
Encompass Health Common Stock financial
"security_title": "Encompass Health Common Stock""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HERMAN JOAN E
(Last)(First)(Middle)
9001 LIBERTY PARKWAY
(Street)
BIRMINGHAM ALABAMA 35242
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock05/07/2026A1,634(1)A$049,558D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
/s/ Patrick Darby, attorney-in-fact for Joan E. Herman05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Encompass Health (EHC) report for Joan E. Herman?

Encompass Health reported that director Joan E. Herman received a grant of 1,634 common shares. This was an annual restricted stock unit award under the 2025 Omnibus Performance Incentive Plan, reflecting routine equity-based compensation rather than an open-market trade.

Was the Encompass Health (EHC) transaction a stock purchase or sale by Joan E. Herman?

The transaction was not a market purchase or sale; it was a grant. Herman received 1,634 shares as a restricted stock unit award, which is part of her director compensation and involved no cash price per share in this filing.

How many Encompass Health (EHC) shares does Joan E. Herman hold after this Form 4?

After the reported grant, Joan E. Herman directly holds 49,558 Encompass Health common shares. This total includes the 1,634 shares granted as part of her annual restricted stock unit award under the company’s 2025 Omnibus Performance Incentive Plan.

What is the source of Joan E. Herman’s 1,634-share grant at Encompass Health (EHC)?

The 1,634-share grant to Joan E. Herman comes from Encompass Health’s 2025 Omnibus Performance Incentive Plan. A footnote explains it is an annual grant of restricted stock units awarded as part of the corporation’s long-term equity compensation program.

Does the Encompass Health (EHC) Form 4 indicate any derivatives or option exercises for Joan E. Herman?

The Form 4 does not show any derivative or option exercises for Joan E. Herman. It reports only a single non-derivative transaction, which is the grant of 1,634 common shares as restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan.